177 lines
14 KiB
HTML
177 lines
14 KiB
HTML
<!DOCTYPE html>
|
||
<html lang="fr">
|
||
<head>
|
||
<meta charset="UTF-8"><meta name="viewport" content="width=device-width,initial-scale=1.0">
|
||
<title>MedReach — Projection Campagne Ethica</title>
|
||
<link href="https://fonts.googleapis.com/css2?family=DM+Sans:wght@400;500;600;700&family=JetBrains+Mono:wght@400;500&display=swap" rel="stylesheet">
|
||
<style>
|
||
:root{--bg:#0a0c14;--s1:#111827;--s2:#1a1f35;--border:#1e293b;--t1:#f1f5f9;--t2:#94a3b8;--t3:#64748b;--accent:#7c3aed;--teal:#10b981;--amber:#f59e0b;--red:#ef4444;--blue:#3b82f6}
|
||
*{margin:0;padding:0;box-sizing:border-box}
|
||
body{font-family:'DM Sans',sans-serif;background:var(--bg);color:var(--t1);min-height:100vh}
|
||
.top{display:flex;justify-content:space-between;align-items:center;padding:24px 40px;border-bottom:1px solid var(--border)}
|
||
.logo{display:flex;align-items:center;gap:14px}
|
||
.logo-mark{width:40px;height:40px;background:linear-gradient(135deg,var(--accent),#a855f7);border-radius:10px;display:flex;align-items:center;justify-content:center;font-weight:700;color:#fff;font-size:18px}
|
||
.logo h1{font-size:20px;font-weight:700;letter-spacing:-.5px}
|
||
.logo h1 span{color:var(--accent);font-weight:400}
|
||
.logo-sub{font-size:11px;color:var(--t3);margin-top:2px}
|
||
.nav-top{display:flex;gap:8px}
|
||
.nav-top a{padding:8px 16px;border-radius:8px;font-size:13px;font-weight:500;color:var(--t2);text-decoration:none;border:1px solid var(--border);transition:all .2s}
|
||
.nav-top a:hover,.nav-top a.active{background:var(--accent);color:#fff;border-color:var(--accent)}
|
||
.container{max-width:1300px;margin:0 auto;padding:32px 40px}
|
||
.section-title{font-size:11px;font-weight:600;text-transform:uppercase;letter-spacing:.1em;color:var(--accent);margin-bottom:16px}
|
||
h2{font-size:22px;font-weight:700;margin-bottom:6px}
|
||
.subtitle{color:var(--t3);font-size:13px;margin-bottom:24px}
|
||
.summary-row{display:grid;grid-template-columns:repeat(4,1fr);gap:12px;margin-bottom:32px}
|
||
.summary{background:var(--s1);border:1px solid var(--border);border-radius:14px;padding:20px;text-align:center}
|
||
.summary .val{font-family:'JetBrains Mono',monospace;font-size:32px;font-weight:700}
|
||
.summary .lbl{font-size:11px;color:var(--t3);text-transform:uppercase;letter-spacing:.06em;margin-top:4px}
|
||
.green{color:var(--teal)}.amber{color:var(--amber)}.purple{color:var(--accent)}.blue{color:var(--blue)}.red{color:var(--red)}
|
||
.brands-grid{display:grid;grid-template-columns:repeat(3,1fr);gap:14px;margin-bottom:32px}
|
||
.brand-card{background:var(--s1);border:1px solid var(--border);border-radius:14px;padding:20px;transition:all .2s;position:relative;overflow:hidden}
|
||
.brand-card:hover{border-color:var(--accent);transform:translateY(-2px)}
|
||
.brand-card .pill{position:absolute;top:12px;right:12px;font-size:10px;padding:3px 8px;border-radius:6px;font-weight:600}
|
||
.pill-tn{background:rgba(239,68,68,.15);color:var(--red)}
|
||
.pill-dz{background:rgba(16,185,129,.15);color:var(--teal)}
|
||
.pill-ma{background:rgba(245,158,11,.15);color:var(--amber)}
|
||
.pill-multi{background:rgba(124,58,237,.15);color:var(--accent)}
|
||
.brand-card h3{font-size:15px;font-weight:600;margin-bottom:4px;display:flex;align-items:center;gap:8px}
|
||
.brand-card h3 .icon{font-size:18px}
|
||
.brand-card .specs{font-size:11px;color:var(--t3);margin-bottom:12px}
|
||
.brand-card .metrics{display:grid;grid-template-columns:1fr 1fr;gap:8px}
|
||
.brand-card .metric{padding:8px;background:rgba(255,255,255,.02);border-radius:8px}
|
||
.brand-card .metric b{display:block;font-family:'JetBrains Mono',monospace;font-size:15px;color:var(--t1)}
|
||
.brand-card .metric span{font-size:10px;color:var(--t3)}
|
||
.funnel{background:var(--s1);border:1px solid var(--border);border-radius:14px;padding:28px;margin-bottom:32px}
|
||
.funnel h3{font-size:15px;font-weight:600;margin-bottom:20px}
|
||
.funnel-steps{display:flex;align-items:center;gap:0}
|
||
.funnel-step{flex:1;text-align:center;position:relative}
|
||
.funnel-bar{height:48px;display:flex;align-items:center;justify-content:center;font-family:'JetBrains Mono',monospace;font-size:16px;font-weight:700;color:#fff;border-radius:8px;margin-bottom:8px}
|
||
.funnel-step .lbl{font-size:11px;color:var(--t3)}
|
||
.funnel-step .pct{font-size:10px;color:var(--t2);margin-top:2px}
|
||
.arrow{width:24px;flex-shrink:0;text-align:center;color:var(--t3);font-size:18px;padding-top:0}
|
||
.compare{background:var(--s1);border:1px solid var(--border);border-radius:14px;overflow:hidden;margin-bottom:32px}
|
||
.compare h3{padding:20px 24px 0;font-size:15px;font-weight:600;margin-bottom:16px}
|
||
table{width:100%;border-collapse:collapse;font-size:13px}
|
||
th{text-align:left;padding:12px 16px;font-size:11px;color:var(--t3);text-transform:uppercase;letter-spacing:.06em;font-weight:600;border-bottom:1px solid var(--border);background:rgba(255,255,255,.02)}
|
||
td{padding:10px 16px;border-bottom:1px solid rgba(255,255,255,.03);color:var(--t2)}
|
||
td:first-child{color:var(--t1);font-weight:500}
|
||
.tag{display:inline-block;padding:2px 8px;border-radius:4px;font-size:10px;font-weight:600}
|
||
.tag-win{background:rgba(16,185,129,.15);color:var(--teal)}
|
||
.tag-avg{background:rgba(245,158,11,.15);color:var(--amber)}
|
||
.footer{text-align:center;padding:32px;color:var(--t3);font-size:11px;border-top:1px solid var(--border)}
|
||
.footer a{color:var(--accent);text-decoration:none}
|
||
</style>
|
||
</head>
|
||
<body>
|
||
<div class="top">
|
||
<div class="logo">
|
||
<div class="logo-mark">M</div>
|
||
<div>
|
||
<h1>Med<span>Reach</span></h1>
|
||
<div class="logo-sub">Projection Campagne — Ethica Pharma 2026</div>
|
||
</div>
|
||
</div>
|
||
<div class="nav-top">
|
||
<a href="medreach-dashboard.html">📊 Reach Report</a>
|
||
<a href="medreach-campaign.html" class="active">🚀 Projection Campagne</a>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="container">
|
||
<div class="section-title">Projection annuelle</div>
|
||
<h2>Simulation Campagne Email — 18 Marques Ethica</h2>
|
||
<div class="subtitle">Projection basée sur 107 604 HCPs email qualifiés × 13 spécialités × 3 pays</div>
|
||
|
||
<div class="summary-row">
|
||
<div class="summary"><div class="val purple">18</div><div class="lbl">Marques Ethica</div></div>
|
||
<div class="summary"><div class="val green">107 604</div><div class="lbl">Emails Qualifiés</div></div>
|
||
<div class="summary"><div class="val blue">~32%</div><div class="lbl">Taux d'Ouverture Projeté</div></div>
|
||
<div class="summary"><div class="val amber">~5%</div><div class="lbl">Taux de Clic Projeté</div></div>
|
||
</div>
|
||
|
||
<div class="section-title">Funnel de Conversion Projeté</div>
|
||
<div class="funnel">
|
||
<h3>📈 Funnel type — Campagne email mono-marque (ex: Doliprane 1g, cible Généralistes TN+DZ+MA)</h3>
|
||
<div class="funnel-steps">
|
||
<div class="funnel-step">
|
||
<div class="funnel-bar" style="background:linear-gradient(135deg,var(--accent),#a855f7)">10 344</div>
|
||
<div class="lbl">Emails Envoyés</div>
|
||
<div class="pct">Généralistes 3 pays</div>
|
||
</div>
|
||
<div class="arrow">→</div>
|
||
<div class="funnel-step">
|
||
<div class="funnel-bar" style="background:linear-gradient(135deg,var(--blue),#60a5fa)">10 137</div>
|
||
<div class="lbl">Délivrés Inbox</div>
|
||
<div class="pct">98% deliverability</div>
|
||
</div>
|
||
<div class="arrow">→</div>
|
||
<div class="funnel-step">
|
||
<div class="funnel-bar" style="background:linear-gradient(135deg,var(--teal),#34d399)">3 244</div>
|
||
<div class="lbl">Ouvertures</div>
|
||
<div class="pct">32% open rate</div>
|
||
</div>
|
||
<div class="arrow">→</div>
|
||
<div class="funnel-step">
|
||
<div class="funnel-bar" style="background:linear-gradient(135deg,var(--amber),#fbbf24)">517</div>
|
||
<div class="lbl">Clics</div>
|
||
<div class="pct">5% CTR</div>
|
||
</div>
|
||
<div class="arrow">→</div>
|
||
<div class="funnel-step">
|
||
<div class="funnel-bar" style="background:linear-gradient(135deg,#f43f5e,#fb7185)">52</div>
|
||
<div class="lbl">Conversions</div>
|
||
<div class="pct">~10% landing → action</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="section-title">Par Marque</div>
|
||
<div class="brands-grid">
|
||
<div class="brand-card"><span class="pill pill-multi">TN · DZ · MA</span><h3><span class="icon">💊</span> Doliprane 1g</h3><div class="specs">Généraliste, Pédiatre, Rhumatologue, Orthopédiste</div><div class="metrics"><div class="metric"><b>27 424</b><span>Reach email</span></div><div class="metric"><b>8 776</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-tn">TN</span><h3><span class="icon">💊</span> Doliprane Vit C</h3><div class="specs">Généraliste, Pédiatre</div><div class="metrics"><div class="metric"><b>2 754</b><span>Reach email</span></div><div class="metric"><b>881</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-tn">TN</span><h3><span class="icon">💊</span> Doliprane Ped</h3><div class="specs">Pédiatre, Généraliste</div><div class="metrics"><div class="metric"><b>2 754</b><span>Reach email</span></div><div class="metric"><b>881</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-multi">TN · DZ · MA</span><h3><span class="icon">💊</span> Maxilase</h3><div class="specs">ORL, Généraliste, Pédiatre</div><div class="metrics"><div class="metric"><b>22 922</b><span>Reach email</span></div><div class="metric"><b>7 335</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-multi">TN · DZ</span><h3><span class="icon">💊</span> Telfast</h3><div class="specs">Allergologue, Dermatologue, Pneumologue, ORL</div><div class="metrics"><div class="metric"><b>14 069</b><span>Reach email</span></div><div class="metric"><b>4 502</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-multi">TN · DZ</span><h3><span class="icon">💊</span> Nasacort</h3><div class="specs">ORL, Allergologue, Pneumologue, Généraliste</div><div class="metrics"><div class="metric"><b>22 235</b><span>Reach email</span></div><div class="metric"><b>7 115</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-multi">MA · TN</span><h3><span class="icon">💊</span> Enterogermina</h3><div class="specs">Gastro-entérologue, Généraliste, Pédiatre</div><div class="metrics"><div class="metric"><b>16 760</b><span>Reach email</span></div><div class="metric"><b>5 363</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-ma">MA</span><h3><span class="icon">💊</span> No Spa</h3><div class="specs">Gastro-entérologue, Généraliste, Pédiatre</div><div class="metrics"><div class="metric"><b>3 680</b><span>Reach email</span></div><div class="metric"><b>1 178</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-multi">TN · DZ · MA</span><h3><span class="icon">💊</span> Aspégic</h3><div class="specs">Généraliste, Cardiologue, Rhumatologue</div><div class="metrics"><div class="metric"><b>21 119</b><span>Reach email</span></div><div class="metric"><b>6 758</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-ma">MA</span><h3><span class="icon">💊</span> Flagyl</h3><div class="specs">Gastro-entérologue, Dermatologue, Généraliste</div><div class="metrics"><div class="metric"><b>3 172</b><span>Reach email</span></div><div class="metric"><b>1 015</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-ma">MA</span><h3><span class="icon">💊</span> Uvedose</h3><div class="specs">Généraliste, Endocrinologue, Rhumatologue</div><div class="metrics"><div class="metric"><b>2 419</b><span>Reach email</span></div><div class="metric"><b>774</b><span>Ouvertures proj.</span></div></div></div>
|
||
<div class="brand-card"><span class="pill pill-ma">MA</span><h3><span class="icon">💊</span> Allegra</h3><div class="specs">Allergologue, Dermatologue, Pneumologue</div><div class="metrics"><div class="metric"><b>2 152</b><span>Reach email</span></div><div class="metric"><b>689</b><span>Ouvertures proj.</span></div></div></div>
|
||
</div>
|
||
|
||
<div class="section-title">Benchmark vs Marché</div>
|
||
<div class="compare">
|
||
<h3>📊 Comparaison avec les standards sectoriels pharma</h3>
|
||
<table>
|
||
<thead><tr><th>Indicateur</th><th>WEVAL MedReach</th><th>Benchmark Pharma (Mailchimp 2025)</th><th>Benchmark IQVIA</th><th>Statut</th></tr></thead>
|
||
<tbody>
|
||
<tr><td>Taux d'ouverture</td><td><b>28-35%</b></td><td>18-22%</td><td>20-25%</td><td><span class="tag tag-win">+56%</span></td></tr>
|
||
<tr><td>Taux de clic</td><td><b>4-6%</b></td><td>2.5-3%</td><td>3-4%</td><td><span class="tag tag-win">+67%</span></td></tr>
|
||
<tr><td>Bounce rate</td><td><b><2%</b></td><td>3-5%</td><td>2-3%</td><td><span class="tag tag-win">-60%</span></td></tr>
|
||
<tr><td>Délivrabilité inbox</td><td><b>97%+</b></td><td>85-90%</td><td>90-94%</td><td><span class="tag tag-win">+8%</span></td></tr>
|
||
<tr><td>Reach Maghreb total</td><td><b>107 604</b></td><td>—</td><td>~40-60K estimé</td><td><span class="tag tag-win">+80%</span></td></tr>
|
||
<tr><td>Couverture spécialités</td><td><b>32</b></td><td>—</td><td>15-20</td><td><span class="tag tag-win">+60%</span></td></tr>
|
||
<tr><td>Tarif /1K emails</td><td><b>~200€</b></td><td>—</td><td>300-500€</td><td><span class="tag tag-win">-50%</span></td></tr>
|
||
</tbody>
|
||
</table>
|
||
</div>
|
||
|
||
<div style="background:linear-gradient(135deg,rgba(124,58,237,.08),rgba(16,185,129,.06));border:1px solid rgba(124,58,237,.2);border-radius:16px;padding:28px;text-align:center;margin-bottom:32px">
|
||
<h3 style="font-size:18px;margin-bottom:8px">Prêt à lancer ?</h3>
|
||
<p style="color:var(--t3);font-size:13px;max-width:500px;margin:0 auto 16px">107 604 HCPs qualifiés. 18 marques mappées. Infrastructure souveraine opérationnelle.</p>
|
||
<div style="display:flex;gap:12px;justify-content:center">
|
||
<a href="mailto:ymahboub@weval-consulting.com?subject=Ethica%20-%20Lancement%20campagne" style="background:var(--accent);color:#fff;padding:12px 28px;border-radius:10px;font-weight:600;font-size:14px;text-decoration:none">Planifier un call →</a>
|
||
<a href="/booking.html" style="border:1px solid var(--border);color:var(--t1);padding:12px 28px;border-radius:10px;font-weight:500;font-size:14px;text-decoration:none">Réserver un créneau</a>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="footer">
|
||
MedReach by <a href="https://weval-consulting.com">WEVAL Consulting</a> — Sovereign AI & Digital Marketing • Casablanca / Paris<br>
|
||
Projection au 30 mars 2026 • Taux projetés basés sur infrastructure PMTA/DKIM/SPF/DMARC dédiée
|
||
</div>
|
||
</body>
|
||
</html>
|